Kensaku Kasuga
Overview
Explore the profile of Kensaku Kasuga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sato K, Niimi Y, Ihara R, Iwata A, Nemoto K, Arai T, et al.
J Alzheimers Dis Rep
. 2025 Mar;
9:25424823241307639.
PMID: 40034500
Lecanemab, an anti-amyloid therapy for early Alzheimer's disease, received approval by the FDA and Japan in 2023. Public response on social media was scrutinized, aiming to obtain insights into communication...
2.
Hatakeyama Y, Kimura A, Tsuboguchi S, Ratanov M, Nakamura K, Hatakeyama M, et al.
Eur J Nucl Med Mol Imaging
. 2024 Dec;
PMID: 39699685
No abstract available.
3.
Akiyama N, Kanazawa M, Kasuga K, Hatakeyama M, Ikeuchi T, Onodera O
Mov Disord Clin Pract
. 2024 Dec;
PMID: 39688304
Background: Progressive supranuclear palsy (PSP) is a major atypical parkinsonism. Because diagnosis based on the cardinal clinical features is often difficult, misdiagnosis with Parkinson's disease (PD) and multiple system atrophy...
4.
Hofmann A, Hasler L, Lambert M, Kaeser S, Graber-Sultan S, Obermuller U, et al.
Nat Commun
. 2024 Nov;
15(1):9982.
PMID: 39557867
Disease-modifying therapies for Alzheimer's disease (AD) are likely to be most beneficial when initiated in the presymptomatic phase. To track the benefit of such interventions, fluid biomarkers are of great...
5.
Nonaka T, Ae R, Kosami K, Tange H, Kaneko M, Nakagaki T, et al.
Diagnostics (Basel)
. 2024 Nov;
14(21).
PMID: 39518392
Background/objectives: Sporadic Creutzfeldt-Jakob disease (sCJD) is a fatal neurodegenerative disorder traditionally diagnosed based on the World Health Organization (WHO) criteria in 1998. Recently, Hermann et al. proposed updated diagnostic criteria...
6.
Sato K, Niimi Y, Ihara R, Iwata A, Suzuki K, Nemoto K, et al.
Alzheimers Res Ther
. 2024 Oct;
16(1):205.
PMID: 39358780
Background: The approval of lecanemab, an anti-amyloid therapy for Alzheimer's disease (AD), necessitates addressing healthcare preparedness for disease-modifying treatment (DMT) to ensure appropriate, safe, and sustainable drug administration. Understanding public...
7.
Ishiguro T, Kasuga K
Brain Sci
. 2024 Sep;
14(9).
PMID: 39335355
Progressive Supranuclear Palsy (PSP) is the most common four-repeat tauopathy. PSP cases are typically characterized by vertical gaze palsy and postural instability; however, various phenotypes have been reported, making antemortem...
8.
Kuroha Y, Takahashi T, Arai Y, Yoshino M, Kasuga K, Hasegawa A, et al.
Rinsho Shinkeigaku
. 2024 Aug;
64(9):623-631.
PMID: 39198159
This study aimed to clarify associations of clinical and neuropsychological features and change in regional cerebral blood flow (rCBF) on I-IMP-SPECT in patients with Parkinson's disease (PD) who developed dementia....
9.
McDade E, Liu H, Bui Q, Hassenstab J, Gordon B, Benzinger T, et al.
Res Sq
. 2024 Aug;
PMID: 39108475
This study explored the role of the ubiquitin-proteasome system (UPS) in dominantly inherited Alzheimer's disease (DIAD) by examining changes in cerebrospinal fluid (CSF) levels of UPS proteins along with disease...
10.
Kikuchi M, Miyashita A, Hara N, Kasuga K, Saito Y, Murayama S, et al.
Alzheimers Res Ther
. 2024 Jul;
16(1):158.
PMID: 38987831
No abstract available.